RESUMO
BACKGROUND: In this multi-centre, randomised, placebo-controlled pilot trial, we investigated the clinical and haemodynamic effects of the endothelin-receptor blocker Bosentan in patients with heart failure, preserved ejection fraction and pulmonary hypertension (PH-HFpEF). MATERIALS AND METHODS: Eligible patients received either 12 weeks of Bosentan therapy, or a placebo drug. Patients were thereafter followed for a further period of 12 weeks without the study medication. At three points during the study (study Commencement, Week 12 and Week 24), a six-minute walk test (6MWT), echocardiographic and laboratory assessments were performed, as well as a quality of life survey. Right heart catheterisation (RHC) was undertaken at commencement only. The study was aborted early, after an interim analysis favoured the placebo. RESULTS: Six-minute walk distance (6MWD) did not change in the Bosentan group (309.7±96.3m (Commencement), 317.0±126.1m (Week 12), 307.0±84.4m (Week 24); p=0.86), but almost reached statistical significance in the placebo group from 328.8±79.6m, to 361.6±98.2m and 384.0±74.9m (Week 24); p=0.075. In the placebo group, estimated systolic pulmonary artery pressure (measured via echocardiography) significantly decreased (from 62.3±16.7mmHg [Commencement], 45.3±13.9mmHg [Week 12], to 44.6±14.5mmHg [Week 24]; p=0.014) as did right atrial pressure (13.1±5.3 [Commencement], 10.0±3.8 [Week 12], to 9.4±3.2 [Week 24]; p=0.046). CONCLUSION: Despite this study's limited sample size and premature cessation, it nevertheless suggests that endothelin receptor blockade in patients with PH-HFpEF may have no beneficial effects and could even be detrimental in comparison to a placebo.
Assuntos
Antagonistas dos Receptores de Endotelina/administração & dosagem , Insuficiência Cardíaca Diastólica/tratamento farmacológico , Hipertensão Pulmonar/tratamento farmacológico , Sulfonamidas/administração & dosagem , Idoso , Bosentana , Antagonistas dos Receptores de Endotelina/efeitos adversos , Insuficiência Cardíaca Diastólica/complicações , Insuficiência Cardíaca Diastólica/fisiopatologia , Humanos , Hipertensão Pulmonar/complicações , Hipertensão Pulmonar/fisiopatologia , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Sulfonamidas/efeitos adversosRESUMO
The breast and ovarian cancer susceptibility gene, BRCA1, has been cloned and shown to encode a zinc-finger protein of unknown function. Mutations in BRCA1 account for at least 80% of families with both breast and ovarian cancer, as well as some non-familial sporadic ovarian cancers. The loss of wild-type BRCA1 in tumours of individuals carrying one nonfunctional BRCA1 allele suggests that BRCA1 encodes a tumour suppressor that may inhibit the proliferation of mammary epithelial cells. To examine the role of BRCA1 in normal tissue growth and differentiation, and to generate a potential model for the cancer susceptibility associated with loss of BRCA1 function, we have created a mouse line carrying a mutation in one Brca1 allele. Analysis of mice homozygous for the mutant allele indicate that Brca1 is critical for normal development, as these mice died in utero between 10 and 13 days of gestation (E10-E13). Abnormalities in Brca1-deficient embryos were most evident in the neural tube, with 40% of the embryos presenting with varying degrees of spina bifida and anencephaly. In addition, the neuroepithelium in Brca1-deficient embryos appeared disorganized, with signs of both rapid proliferation and excessive cell death.
Assuntos
Sistema Nervoso Central/embriologia , Desenvolvimento Embrionário e Fetal/genética , Proteínas de Neoplasias/fisiologia , Fatores de Transcrição/fisiologia , Anencefalia/embriologia , Anencefalia/genética , Animais , Proteína BRCA1 , Sequência de Bases , Epitélio/embriologia , Feminino , Marcação de Genes , Genes Letais , Homozigoto , Masculino , Camundongos , Camundongos Mutantes , Dados de Sequência Molecular , Proteínas de Neoplasias/genética , RNA Mensageiro/análise , Disrafismo Espinal/embriologia , Disrafismo Espinal/genética , Fatores de Transcrição/genéticaRESUMO
BACKGROUND: Studies in both human and mouse indicate that mediators released by mast cells can lead to bronchoconstriction, and thus these are important effector cells in lifethreatening anaphylaxis. Much of our understanding of the various functions of mast cells emanates from the study of mice lacking these cells, particularly mice carrying mutations in the tyrosine kinase gene Kit. Definitive evidence for the role of mast cells in the altered immune response requires the demonstration that this response can be normalized by reconstitution of the mice with cultured bone marrow-derived mast cells (BMMCs). While many mast cell niches can be restored with BMMCs, this has not been demonstrated for mast cells present in the airways of the lung, cells poised to mediate bronchoconstriction during allergic responses. OBJECTIVE: To determine if mast cell-deficient Kit(Wsh/Wsh) reconstituted lines are an appropriate model for the study of the role of these cells in bronchoconstriction associated with allergic responses. METHODS: Kit(Wsh/Wsh) mice were reconstituted with either whole bone marrow (WBM) or BMMCs and responses to IgE-mediated mast cell activation were determined; including systemic hypothermia, mediator release, and bronchoconstriction in anaesthetized, mechanically ventilated animals. RESULTS: Engraftment of Kit(Wsh/Wsh) mice with WBM and BMMCs results in reconstitution of the central airways with mast cells. While the treatment of the two groups of animals resulted in systemic changes when challenged with IgE/Ag in a model of passive anaphylaxis, bronchoconstriction was observed only in kit(Wsh/Wsh) animals, which had received a bone marrow transplant. CONCLUSIONS: While BMMCs can populate the lung, they cannot restore IgE/Ag-mediated bronchoconstriction to mast cell-deficient animals. This suggests that the mast cell population, which mediates this function, may be unique, and to fill this niche in the lung cells must undergo a specific developmental programme, one that is no longer available to cultured mast cells.
Assuntos
Antígenos/imunologia , Broncoconstrição/imunologia , Pulmão/citologia , Pulmão/imunologia , Mastócitos/imunologia , Animais , Inflamação , Camundongos , Camundongos Endogâmicos C57BL , Neurônios/imunologiaRESUMO
Platelet activation is characterized by shape change, induction of fibrinogen receptor expression and release of granular contents, leading to aggregation and plug formation. While this response is essential for hemostasis, it is also important in the pathogenesis of a broad spectrum of diseases, including myocardial infarction, stroke and unstable angina. Adenosine 5'-diphosphate (ADP) induces platelet aggregation, but the mechanism for this has not been established, and the relative contribution of ADP in hemostasis and the development of arterial thrombosis is poorly understood. We show here that the purinoceptor P2Y1 is required for platelet shape change in response to ADP and is also a principal receptor mediating ADP-induced platelet aggregation. Activation of P2Y1 resulted in increased intracellular calcium but no alteration in cyclic adenosine monophosphate (cAMP) levels. P2Y1-deficient platelets partially aggregated at higher ADP concentrations, and the lack of P2Y1 did not alter the ability of ADP to inhibit cAMP, indicating that platelets express at least one additional ADP receptor. In vivo, the lack of P2Y1 expression increased bleeding time and protected from collagen- and ADP-induced thromboembolism. These findings support the hypothesis that the ATP receptor P2Y1 is a principal receptor mediating both physiologic and pathological ADP-induced processes in platelets.
Assuntos
Difosfato de Adenosina/farmacologia , Agregação Plaquetária/fisiologia , Receptores Purinérgicos P2/deficiência , Tromboembolia/etiologia , Animais , Tempo de Sangramento , Plaquetas/citologia , Plaquetas/efeitos dos fármacos , Tamanho Celular , AMP Cíclico , Imunidade Inata , Camundongos , Camundongos Mutantes , Modelos Biológicos , Mutagênese , Receptores Purinérgicos P2/genética , Receptores Purinérgicos P2Y1RESUMO
BACKGROUND: Cranial ultrasound (cUS) findings help doctors in the clinical management of preterm infants and in their discussion with parents regarding prediction of outcome. cUS is often used as outcome measure in clinical research studies. Accurate cUS performance and interpretation is therefore required. AIMS: The aims of this study were (i) to assess the interobserver variability in cUS interpretation, and (ii) to evaluate whether level of cUS expertise influences the interobserver variability. METHODS: Fifty-eight cUS image series of preterm infants born below 32 weeks of gestation collected within the Swiss Neonatal Network were sent to 27 observers for reviewing. Observers were grouped into radiologists, experienced neonatologists and less experienced neonatologists. Agreement between observers was calculated using Kappa statistics. RESULTS: When cystic periventricular leukomalacia, intraventricular haemorrhage and periventricular haemorrhagic infarction were combined to one outcome, agreement among all observers was moderate. When divided into subgroups, kappa for the combined outcome was 0.7 for experienced neonatologists, 0.67 for radiologists and 0.53 for inexperienced neonatologists. Marked difference in interobserver agreement between experienced neonatologists and radiologists could be found for haemorrhagic periventricular ifraction (HPI). CONCLUSIONS: Our results suggest that interobserver agreement for interpretation of cUS varies from poor to good varying with the type of abnormality and level of expertise, suggesting that widespread structured training should be made available to improve the performance and interpretation of cUS.
Assuntos
Encefalopatias/diagnóstico por imagem , Ecoencefalografia/métodos , Recém-Nascido Prematuro , Feminino , Humanos , Recém-Nascido , Masculino , Variações Dependentes do Observador , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , SuíçaRESUMO
We describe here the isolation and sequencing of a previously uncharacterized HLA class I gene. This gene, HLA-5.4, is the third non-HLA-A,B,C gene characterized whose sequence shows it encodes an intact class I protein. RNase protection assays with a probe specific for this gene demonstrated its expression in B lymphoblastoid cell lines, in resting T cells, and skin cells, while no mRNA could be detected in the T cell line Molt 4. Consistent with a pattern of expression different from that of other class I genes, DNA sequence comparisons identified potential regulator motifs unique to HLA-5.4 and possibly essential for tissue-specific expression. Protein sequence analysis of human and murine class I antigens has identified 10 highly conserved residues believed to be involved in antigen binding. Five of these are altered in HLA-5.4, and of these, three are nonconservative. In addition, examination of the HLA-5.4 DNA sequence predicts that the cytoplasmic segment of this protein is shorter than that of the classical transplantation antigens. The 3' untranslated region of the HLA-5.4 gene contains one member of a previously undescribed multigene family consisting of at least 30 members. Northern analysis showed that several of these sequences were transcribed, and the most ubiquitous transcript, a 600-nucleotide polyadenylated mRNA, was found in all tissues and cells examined. This sequence is conserved in the mouse genome, where a similar number of copies were found, and one of these sequences was also transcribed, yielding a 600-nucleotide mRNA. The characterization of this unique HLA class I gene and the demonstration of its tissue-specific expression have prompted us to propose that HLA-5.4 be designated HLA-F.
Assuntos
Genes MHC Classe I , Antígenos HLA/genética , Antígenos de Histocompatibilidade Classe I/genética , Sequências Repetitivas de Ácido Nucleico , Transcrição Gênica , Sequência de Aminoácidos , Sequência de Bases , Southern Blotting , DNA/genética , Éxons , Ligação Genética , Humanos , Íntrons , Dados de Sequência Molecular , Regiões Promotoras Genéticas , RNA/genética , Sondas RNA , RNA Antissenso , RNA Mensageiro/antagonistas & inibidores , Mapeamento por Restrição , Homologia de Sequência do Ácido NucleicoRESUMO
Leukotrienes are potent inflammatory mediators synthesized from arachidonic acid (AA) predominately by cells of myeloid origin. The synthesis of these lipids is believed to be dependent not only on the expression of the enzyme 5-lipoxygenase (5-LO), which catalyzes the first steps in the synthesis of leukotrienes, but also on expression of a nuclear membrane protein termed the 5-LO-activating protein (FLAP). To study the relationship of these two proteins in mediating the production of leukotrienes in vivo and to determine whether the membrane protein FLAP has additional functions in various inflammatory processes, we have generated a mouse line deficient in this protein. FLAP-deficient mice develop normally and are healthy. However, an array of assays comparing inflammatory reactions in FLAP-deficient mice and in normal controls revealed that FLAP plays a role in a subset of these reactions. Although examination of DTH and IgE-mediated passive anaphylaxis showed no difference between wild-type and FLAP-deficient animals, mice without FLAP possessed a blunted inflammatory response to topical AA and had increased resistance to platelet-activating factor-induced shock compared to controls. Also, edema associated with Zymosan A-induced peritonitis was markedly reduced in animals lacking FLAP. To determine whether these differences relate solely to a deficit in leukotriene production, or whether they reflect an additional role for FLAP in inflammation, we compared the FLAP-deficient mice to 5-LO-deficient animals. Evaluation of mice lacking FLAP and 5-LO indicated that production of leukotrienes during inflammatory responses is dependent upon the availability of FLAP and did not support additional functions for FLAP beyond its role in leukotriene production.
Assuntos
Proteínas de Transporte/fisiologia , Inflamação/fisiopatologia , Macrófagos Peritoneais/fisiologia , Proteínas de Membrana/fisiologia , Proteínas Ativadoras de 5-Lipoxigenase , Anafilaxia , Animais , Ácido Araquidônico/farmacologia , Proteínas de Transporte/biossíntese , Proteínas de Transporte/metabolismo , DNA Complementar , Edema , Eicosanoides/biossíntese , Hipersensibilidade Tardia , Imunoglobulina E , Inflamação/imunologia , Macrófagos Peritoneais/efeitos dos fármacos , Proteínas de Membrana/biossíntese , Proteínas de Membrana/deficiência , Proteínas de Membrana/metabolismo , Camundongos , Camundongos Knockout , Peritonite/imunologia , Peritonite/fisiopatologia , Peroxidase/metabolismo , Fator de Ativação de Plaquetas/farmacologia , RNA Mensageiro/biossíntese , Transcrição Gênica , ZimosanRESUMO
17 HLA class I genes have been isolated from the genome of B-lymphoblastoid cell line 721. Sequence analysis and transfection studies indicate that three genes, in addition to those encoding the HLA-A, -B, and -C antigens can direct the synthesis of a class I alpha protein (4, 5, 21). Using gene-specific DNA probes to analyze the presence of restriction fragment-length polymorphisms within a large pedigree and in panel of HLA deletion mutant cell lines, we show here that two of these genes, designated HLA-G and HLA-F, are located on the short arm of chromosome 6 telomeric to the HLA-A locus. The third expressed non-A, -B, and -C class I gene, HLA-E, is located between HLA-A and HLA-C (4). In addition, the remaining 11 class I pseudogenes and gene fragments are localized relative to established markers on chromosome 6p.
Assuntos
Cromossomos Humanos Par 6 , Antígenos de Histocompatibilidade Classe I/genética , Complexo Principal de Histocompatibilidade , Polimorfismo Genético , Polimorfismo de Fragmento de Restrição , Linfócitos B/efeitos da radiação , Deleção Cromossômica , Mapeamento Cromossômico , Clonagem Molecular , Ligação Genética , Humanos , Células Tumorais Cultivadas/efeitos da radiaçãoRESUMO
Ly-6A is a murine antigen which is implicated in lymphocyte activation and may be involved in activation of hematopoietic stem cells. Antibody cross-linking studies and antisense experiments have suggested that Ly-6A is a lymphocyte coactivation molecule. To better understand the function of Ly-6A, we used gene targeting to produce Ly-6A null mice which are healthy and have normal numbers and percentages of hematopoietic lineages. However, T lymphocytes from Ly-6A-deficient animals proliferate at a significantly higher rate in response to antigens and mitogens than wild-type littermates. In addition, Ly-6A mutant splenocytes generate more cytotoxic T lymphocytes compared to wild-type splenocytes when cocultured with alloantigen. This enhanced proliferation is not due to alterations in kinetics of response, sensitivity to stimulant concentration, or cytokine production by the T cell population, and is manifest in both in vivo and in vitro T cell responses. Moreover, T cells from Ly-6A-deficient animals exhibit a prolonged proliferative response to antigen stimulation, thereby suggesting that Ly-6A acts to downmodulate lymphocyte responses.
Assuntos
Antígenos Ly/imunologia , Ativação Linfocitária , Proteínas de Membrana/imunologia , Linfócitos T/imunologia , Animais , Anticorpos/sangue , Anticorpos/imunologia , Antígenos Ly/genética , Medula Óssea/imunologia , Células da Medula Óssea , Células Cultivadas , Concanavalina A/farmacologia , Reagentes de Ligações Cruzadas , Regulação para Baixo , Citometria de Fluxo , Marcação de Genes , Hematopoese , Células-Tronco Hematopoéticas/citologia , Células-Tronco Hematopoéticas/imunologia , Hemocianinas/imunologia , Isoantígenos/imunologia , Proteínas de Membrana/genética , Camundongos , Camundongos Knockout , Baço/citologia , Baço/imunologia , Linfócitos T/citologia , Linfócitos T Citotóxicos/citologia , Linfócitos T Citotóxicos/imunologiaRESUMO
Collagen-induced arthritis in the DBA/1 mouse is an experimental model of human rheumatoid arthritis. To examine the role of leukotrienes in the pathogenesis of this disease, we have developed embryonic stem (ES) cells from this mouse strain. Here, we report that DBA/1 mice made deficient in 5-lipoxygenase-activating protein (FLAP) by gene targeting in ES cells develop and grow normally. Zymosan-stimulated leukotriene production in the peritoneal cavity of these mice is undetectable, whereas they produce substantial amounts of prostaglandins. The inflammatory response to zymosan is reduced in FLAP-deficient mice. The severity of collagen-induced arthritis in the FLAP-deficient mice was substantially reduced when compared with wild-type or heterozygous animals. This was not due to an immunosuppressive effect, because anti-collagen antibody levels were similar in wild-type and FLAP-deficient mice. These data demonstrate that leukotrienes play an essential role in both the acute and chronic inflammatory response in mice.
Assuntos
Artrite Experimental/fisiopatologia , Proteínas de Transporte/metabolismo , Proteínas de Transporte/fisiologia , Colágeno/imunologia , Proteínas de Membrana/deficiência , Proteínas de Membrana/metabolismo , Proteínas de Membrana/fisiologia , Proteínas Ativadoras de 5-Lipoxigenase , Animais , Formação de Anticorpos , Artrite Experimental/patologia , Artrite Experimental/prevenção & controle , Proteínas Sanguíneas/metabolismo , Feminino , Heterozigoto , Humanos , Articulações/imunologia , Articulações/patologia , Leucotrienos/biossíntese , Leucotrienos/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos DBA , Camundongos Knockout , Cavidade Peritoneal , Células-Tronco , Zimosan/farmacologiaRESUMO
SUMMARY: We recruited a population-based sample of 58 males and 74 females aged 20-79 from a primary care medical practice to provide normative and descriptive data for high-resolution peripheral quantitative computed tomography (pQCT) parameters. Important effects of ageing and contrasts in the effects of sex on the micro-architecture and strength of upper and lower limb bones were revealed. INTRODUCTION: The advent of high-resolution pQCT scanners has permitted non-invasive assessment of structural data on cortical and trabecular bone. METHODS: We investigated age-related changes in pQCT and finite element (FE) modelling parameters at the distal radius and distal tibia in a population-based cross-sectional study of 58 males and 74 females aged 20-79 years. Linear regression models including quadratic terms for age were used for inference. RESULTS: Age-related changes and sex differences were generally similar for pQCT parameters at the radius and tibia. At each site, mean values for bone density, cortical thickness and trabecular micro-architecture (number, separation and thickness) were lower (trabecular separation higher) in women than men. Changes with age were most apparent for bone density and cortical thickness, which declined with age, in contrast to trabecular micro-architecture parameters which were not significantly associated with age (p > 0.05) in either sex. Cortical bone density and thickness declined faster in women than men after age 50 and trabecular bone density was consistently lower in women. FE-analysis predicted failure load decreased with age and percentage of load carried by trabecular bone increased (p < 0.05). CONCLUSIONS: These data show contrasts in the effects of sex on the micro-architecture and strength of upper and lower limb bones with ageing. The faster decline in cortical bone thickness and density in women than men after age 50 and consistently lower trabecular bone density in women have implications for the excess risks of wrist and hip fractures in women.
Assuntos
Envelhecimento/fisiologia , Rádio (Anatomia)/fisiologia , Tíbia/fisiologia , Absorciometria de Fóton/métodos , Adulto , Idoso , Envelhecimento/patologia , Métodos Epidemiológicos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Rádio (Anatomia)/anatomia & histologia , Rádio (Anatomia)/diagnóstico por imagem , Valores de Referência , Caracteres Sexuais , Tíbia/anatomia & histologia , Tíbia/diagnóstico por imagem , Tomografia Computadorizada por Raios X/métodos , Adulto JovemRESUMO
Neutrophils, the prototypic cells of the innate immune system, are recruited to infected sites to protect the human body from invading pathogens. To accomplish this function, neutrophils sense pathogens and endogenous damage-associated molecules via innate immune receptors, such as Toll-like receptors (TLRs) and other pattern recognition receptors. This defence function is essential for the pulmonary microenvironment where the host is faced with millions of particles and pathogens inhaled daily. Chronic lung diseases, such as cystic fibrosis or chronic obstructive pulmonary disease are characterized by a neutrophil accumulation and chronic bacterial colonization of the airways. Consequently, insights into the role of TLRs on neutrophils in chronic lung diseases are of high relevance for further diagnostic and therapeutic approaches. Here we summarize and discuss recent advances in the expression, regulation and functional role of TLRs on neutrophils in chronic lung diseases.
Assuntos
Pneumopatias/imunologia , Neutrófilos/imunologia , Receptores Imunológicos/imunologia , Receptores Toll-Like/imunologia , Doença Crônica , Humanos , Imunidade Inata , Pneumopatias/genética , Receptores Imunológicos/genética , Receptores Toll-Like/genéticaRESUMO
Major histocompatibility class I proteins display viral and self antigens to potentially responsive cells and are important for the maturation of T cells; beta 2-microglobulin (beta 2M) is required for their normal expression. Mouse chimeras derived from embryonic stem cells with a disrupted beta 2M gene transmitted the inactivated gene to their progeny. Animals homozygous for the mutated beta 2M gene were obtained at expected frequencies after further breeding. The homozygotes appeared normal, although no class I antigens could be detected on their cells and the animals are grossly deficient in CD4- CD8+ T cells, which normally mediate cytotoxic T cell function.
Assuntos
Antígenos de Diferenciação de Linfócitos T/genética , Antígenos de Histocompatibilidade Classe I/genética , Mutação , Linfócitos T/imunologia , Microglobulina beta-2/deficiência , Animais , Antígenos CD4/genética , Antígenos CD8 , Quimera , Expressão Gênica , Genes , Genes MHC Classe I , Linfonodos/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Baço/imunologia , Microglobulina beta-2/genéticaRESUMO
The effect of the number of cystic fibrosis (CF) alleles on cholera toxin (CT)-induced intestinal secretion was examined in the CF mouse model. CF mice that expressed no CF transmembrane conductance regulator (CFTR) protein did not secrete fluid in response to CT. Heterozygotes expressed 50 percent of the normal amount of CFTR protein in the intestinal epithelium and secreted 50 percent of the normal fluid and chloride ion in intestinal epithelium and secreted 50 percent of the normal fluid and chloride ion and fluid secretion suggests that CF heterozygotes might possess a selective advantage of resistance to cholera.
Assuntos
Líquidos Corporais/metabolismo , Cloretos/metabolismo , Toxina da Cólera/toxicidade , Fibrose Cística/genética , Mucosa Intestinal/metabolismo , Proteínas de Membrana/genética , Alelos , Animais , Canais de Cloreto/metabolismo , Cruzamentos Genéticos , AMP Cíclico/metabolismo , Fibrose Cística/fisiopatologia , Regulador de Condutância Transmembrana em Fibrose Cística , Feminino , Heterozigoto , Intestino Delgado/metabolismo , Masculino , Proteínas de Membrana/metabolismo , CamundongosRESUMO
Intracranial infection of normal mice with lymphocytic choriomeningitis virus (LCMV) causes meningitis and death mediated by CD8+ major histocompatibility complex (MHC) class I-restricted cytotoxic T lymphocytes (CTLs). beta 2-Microglobulin-deficient mice (beta 2M-/-) do not express functional MHC class I proteins and do not produce significant numbers of CD8+ T cells. When beta 2M-/- mice were infected with LCMV, many died from LCMV disease and produced a specific response to LCMV mediated by CD4+ CTLs that were class II-restricted. In these mice, CD4+ CTLs may compensate for the lack of CD8+ CTLs.
Assuntos
Antígenos de Histocompatibilidade Classe II/imunologia , Coriomeningite Linfocítica/imunologia , Linfócitos T Citotóxicos/imunologia , Microglobulina beta-2/deficiência , Animais , Linfócitos T CD4-Positivos/imunologia , Antígenos CD8/imunologia , Citotoxicidade Imunológica , Antígenos H-2/imunologia , Depleção Linfocítica , Vírus da Coriomeningite Linfocítica , Camundongos , Camundongos Endogâmicos C57BL , Baço/imunologiaRESUMO
Cystic fibrosis results from defects in the gene encoding a cyclic adenosine monophosphate-dependent chloride ion channel known as the cystic fibrosis transmembrane conductance regulator (CFTR). To create an animal model for cystic fibrosis, mice were generated from embryonic stem cells in which the CFTR gene was disrupted by gene targeting. Mice homozygous for the disrupted gene display many features common to young human cystic fibrosis patients, including failure to thrive, meconium ileus, alteration of mucous and serous glands, and obstruction of glandlike structures with inspissated eosinophilic material. Death resulting from intestinal obstruction usually occurs before 40 days of age.
Assuntos
Fibrose Cística/genética , Modelos Animais de Doenças , Proteínas de Membrana/genética , Animais , Fibrose Cística/patologia , Fibrose Cística/fisiopatologia , Regulador de Condutância Transmembrana em Fibrose Cística , Sistema Digestório/metabolismo , Sistema Digestório/patologia , Glândulas Exócrinas/patologia , Vesícula Biliar/patologia , Genitália Masculina/patologia , Genótipo , Crescimento , Obstrução Intestinal/etiologia , Obstrução Intestinal/patologia , Fígado/patologia , Masculino , Mecônio/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Muco/metabolismo , Mutagênese , Pâncreas/patologia , RNA Mensageiro/metabolismo , Glândulas Salivares/patologiaRESUMO
The cystic fibrosis transmembrane conductance regulator (CFTR) gene encodes an adenosine 3',5'-monophosphate (cyclic AMP)-activated chloride channel. In cystic fibrosis (CF) patients, loss of CFTR function because of a genetic mutation results in defective cyclic AMP-mediated chloride secretion across epithelia. Because of their potential role as an animal model for CF, mice with targeted disruption of the murine CFTR gene [CFTR(-/-)] were tested for abnormalities in epithelial chloride transport. In both freshly excised tissue from the intestine and in cultured epithelia from the proximal airways, the cyclic AMP-activated chloride secretory response was absent in CFTR(-/-) mice as compared to littermate controls. Thus, disruption of the murine CFTR gene results in the chloride transport abnormalities predicted from studies of human CF epithelia.
Assuntos
Cloretos/metabolismo , Fibrose Cística/metabolismo , Modelos Animais de Doenças , Proteínas de Membrana/fisiologia , Amilorida/farmacologia , Animais , Transporte Biológico , Células Cultivadas , Colforsina/farmacologia , AMP Cíclico/farmacologia , Fibrose Cística/genética , Regulador de Condutância Transmembrana em Fibrose Cística , Epitélio/metabolismo , Mucosa Intestinal/metabolismo , Proteínas de Membrana/genética , Camundongos , Mutação , Mucosa Nasal/metabolismo , Traqueia/metabolismoRESUMO
The breast and ovarian cancer susceptibility gene BRCA1 encodes a zinc finger protein of unknown function. Association of the BRCA1 protein with the DNA repair protein Rad51 and changes in the phosphorylation and cellular localization of the protein after exposure to DNA-damaging agents are consistent with a role for BRCA1 in DNA repair. Here, it is shown that mouse embryonic stem cells deficient in BRCA1 are defective in the ability to carry out transcription-coupled repair of oxidative DNA damage, and are hypersensitive to ionizing radiation and hydrogen peroxide. These results suggest that BRCA1 participates, directly or indirectly, in transcription-coupled repair of oxidative DNA damage.
Assuntos
Proteína BRCA1/fisiologia , Reparo do DNA , Alelos , Animais , Proteína BRCA1/genética , Linhagem Celular , Dano ao DNA , Peróxido de Hidrogênio , Camundongos , Oxirredução , Células-Tronco , Timina/análogos & derivados , Timina/imunologia , Timina/metabolismo , Transcrição Gênica , Raios UltravioletaRESUMO
The impact of several physical quantities on the spatial resolution of an X-ray scintillating pixel detector for a micro cone beam CT (µCBCT) is investigated and discussed. The XtremeCT from SCANCO Medical AG was simulated using the EGSnrc/EGS++ Monte Carlo (MC) framework and extensively benchmarked in a previous work. The resolution of the detector was determined by simulating a titanium knife-edge to obtain the edge spread function (ESF) and the modulation transfer function (MTF). Propagation of the scintillation light through the scintillator and its coupling into the fiber optics system was taken into account. The contribution of particles scattered in the main scanner components to the detector signal is very low and does not affect the spatial resolution of the detector. The resolution obtained from the energy deposition in the scintillator without any blurring due to the propagation of the scintillation light into the fiber optics array was 31⯵m. By assuming isotropic light propagation in the scintillator, the resolution degraded to 360⯵m. A simple light propagation model taking into account the impact of the scintillator's columnar microstructures was developed and compared with the MANTIS Monte Carlo simulation package. By reducing the width of the model's light propagation kernel by a factor of 2 compared to the isotropic case, the detector resolution can be improved to 83⯵m, which corresponds well to the measured resolution of 86⯵m. The resolution of the detector is limited mainly by the propagation of the scintillation light through the scintillator layer. It offers the greatest potential to improve the resolution of the µCBCT imaging system.
Assuntos
Tomografia Computadorizada de Feixe Cônico/instrumentação , Método de Monte Carlo , Contagem de Cintilação/instrumentação , LuzRESUMO
BACKGROUND: The Boston Keratoprosthesis (B-KPro) is a therapeutic option for corneal replacement for visual rehabilitation in eyes with poor a prognosis for penetrating keratoplasty (high-risk eyes). Since 2009, this approach has been used in the MVZ Prof. Neuhann, Munich, and since 2013 also at the Department of Ophthalmology, University of Cologne. An overview of results from the first 73 eyes in these departments is presented. METHODS: All recipient eyes of both centers which received a B-KPro type I (BI-KPro) between November 2009 and March 2017 were included. Indications, preoperative findings, intraoperative procedures, and clinical results, as well as postoperative complication and retention rates were documented and analyzed. RESULTS: A total of 73 eyes from 68 patients (mean age 55 ± 21.1 years, range 7 months-93 years; 26 women, 42 men) were treated with a BI-KPro. In 53 eyes (72.6%) the BI-KPro was implanted due to corneal graft failure, whereas BI-KPro was used as the primary corneal replacement in 20 eyes (27.4%). In 46 eyes (63.0%) a long-term increase in visual acuity was achieved and in 21.9% visual acuity was stabilized, while a decrease in preoperative visual acuity occurred in 15.1% of cases. During an average follow-up of 24.7 ± 23.0 months (range 1-78 months), 1.7 ± 2.4 re-interventions (range 0-9) were required. Only 4 keratoprostheses (5.5%) could not be retained. In 3 eyes (4.2%), a change of the BI-KPro device was necessary. CONCLUSION: There is a wide range of indications for BI-KPro in eyes with a poor prognosis for conventional keratoplasty. The surgical technique is safe but with a notable postoperative complication rate, which does not seem to decrease in the medium or long term. The retention rate is excellent for eyes without stem cell deficiency. Nevertheless, the BI-KPro is the only therapeutic option for high-risk eyes and leads to a gain in visual acuity in most cases.